Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms.
about
Targeting Th17 Cells with Small Molecules and Small Interference RNAIntegrating canonical and metabolic signalling programmes in the regulation of T cell responsesDefining the functional states of Th17 cellsThe IL-23-IL-17 immune axis: from mechanisms to therapeutic testingBenzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH 17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγDevelopment of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to SkinTransient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cellsAn activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.Decreased RORC-dependent silencing of prostaglandin receptor EP2 induces autoimmune Th17 cells.Transcription factor co-occupied regions in the murine genome constitute T-helper-cell subtype-specific enhancers.RORγ antagonists and inverse agonists: a patent review.RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cellsTim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation.Small-molecule control of cytokine function: new opportunities for treating immune disordersEmergence of Chinese drug discovery research: impact of hit and lead identification.PLZF regulates CCR6 and is critical for the acquisition and maintenance of the Th17 phenotype in human cells.Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantationThe kinase DYRK1A reciprocally regulates the differentiation of Th17 and regulatory T cells.MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cells.High-density P300 enhancers control cell state transitions.CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell PathogenicityRetinoic Acid-Related Orphan Receptors (RORs): Regulatory Functions in Immunity, Development, Circadian Rhythm, and Metabolism.Digoxin Inhibits Induction of Experimental Autoimmune Uveitis in Mice, but Causes Severe Retinal DegenerationRBPJ Controls Development of Pathogenic Th17 Cells by Regulating IL-23 Receptor Expression.ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer.Tiam1/Rac1 complex controls Il17a transcription and autoimmunity.Protein C receptor (PROCR) is a negative regulator of Th17 pathogenicity.Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritisNdfip1 restricts Th17 cell potency by limiting lineage stability and proinflammatory cytokine productionRetinoic-acid-orphan-receptor-C inhibition suppresses Th17 cells and induces thymic aberrations.Clock-Enhancing Small Molecules and Potential Applications in Chronic Diseases and Aging.Unexpected targets and triggers of autoimmunity.Yin-Yang Regulation of RORγt Protein Complex in Th17 Differentiation.Th17 cells in autoimmune diseases.In vivo regulation of gene expression and T helper type 17 differentiation by RORγt inverse agonists.Brodalumab -an IL-17RA monoclonal antibody for psoriasis and psoriatic arthritis.Harnessing the Therapeutic Potential of Th17 Cells.T-bet as a key regulator of mucosal immunity.A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studies.Role of the JAK/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases.
P2860
Q26770523-C86408B9-2E62-42AD-AFD9-F77B0932429EQ26851446-0C976627-1D1C-494E-A63B-27AACAD05955Q26998296-87529259-4376-493C-A1C6-5BCADF8C913EQ27687800-7E4F2438-FD51-4A3A-8DCB-7721B5DF4763Q27702597-BEE8DC8C-CD36-445C-9368-64E599D2C804Q28550171-0798E311-0724-46EE-B98F-F29B54FA2CB9Q28829881-87EB2DAA-18B9-4BC9-8D2A-48AEDBB747D7Q33798102-C6D7D4A3-2B19-4684-9A4C-502F3460E7F7Q33872546-5880F660-42DC-4AB7-9F9F-A015122230DFQ34490684-B99E6B0E-F344-4BC8-A21F-9E38E0ED2338Q34540327-4AA90B9C-B1AC-402D-81A3-7C8388F456BDQ34831560-C471849D-A9F5-41AC-8511-0FDD9F6154FCQ35137217-2A425701-8722-44DF-8FA3-51B475F077BDQ35252669-90C914BF-C777-45CC-9791-3AE30768B991Q35529100-C1596FC0-4613-4EFC-864B-3DCBB81BE19AQ35546739-F14CA85A-04A6-4A06-902C-2C847CA1F883Q35586614-BC55CB36-7484-422D-9771-AB6161D088E6Q35635336-094194AC-2462-4D62-8117-FBCC27FBBA59Q35745717-1D31FF2C-083E-4AEC-AB88-BB20F3E24181Q35834781-2BB86808-B50B-45DC-8856-A8CBFCB1C5A5Q36352360-6C4724EF-6031-4A19-B772-4F7DE8E9E241Q36571294-7B03480E-253B-4E4C-88CC-ABE0809D6CBFQ36766061-D7479DEB-AABB-47A6-A818-3D816BCAF3FDQ37173575-F86BE332-B0A9-40E3-A718-7F92D1BDACF9Q37270422-7EC473A2-2A1C-44E3-B849-925F15A7BC60Q37336181-D6079149-CE98-4A8E-B74A-0D4545888949Q37346640-6AED1D5B-4DFD-4835-98AD-174FF69026FAQ37460263-4060F030-9291-4458-93FC-EDAE2A02F503Q37554411-D948BD4F-971D-445C-A094-332D32D99EC1Q37677422-F925F569-40C5-4577-A0E9-9F7C58C0025BQ37699510-B388AB66-F2DE-4EB2-B969-6AF11AE0D538Q38208785-5EF4F6D4-2CF7-4D43-B89F-AD61D1DBA14FQ38262156-9C4A4926-2318-4547-A5CC-9C98576474FFQ38344543-62F86125-CDE1-4D2F-B72E-28465041FEA2Q38445801-CD888095-D838-43D6-A193-45AFA827D880Q38488577-FE83F876-4078-4505-A3FE-D03DA1ACD10AQ38535119-B152E206-BBA1-4233-9FDE-77D591620851Q38685822-EA002510-4D05-4ADA-8EA8-FE8C6D76C419Q38968548-F78517E4-427D-4509-A886-E686B1D74516Q38974101-6FAE6938-6405-4180-8218-0799E976E3EA
P2860
Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Small-molecule RORγt antagonis ...... twork by divergent mechanisms.
@ast
Small-molecule RORγt antagonis ...... twork by divergent mechanisms.
@en
type
label
Small-molecule RORγt antagonis ...... twork by divergent mechanisms.
@ast
Small-molecule RORγt antagonis ...... twork by divergent mechanisms.
@en
prefLabel
Small-molecule RORγt antagonis ...... twork by divergent mechanisms.
@ast
Small-molecule RORγt antagonis ...... twork by divergent mechanisms.
@en
P2093
P2860
P50
P1433
P1476
Small-molecule RORγt antagonis ...... twork by divergent mechanisms.
@en
P2093
Alexander Marson
Darby Schmidt
Erkan Baloglu
Jianfei Yang
Jinsong Wang
Karsten Kretschmer
Mark S Sundrud
Mercedes Lobera
P2860
P304
P356
10.1016/J.IMMUNI.2014.04.004
P407
P577
2014-04-01T00:00:00Z